The novel coronavirus has claimed over three lakh lives with over 48 lakh people infected across the globe. In India, 3,029 people have died due to the disease and 100000 have been infected.The herb Ashwagandha can be an effective therapeutic and preventive drug against the COVID-19 infection, a collaborative research by IIT-Delhi and Japan’s National Institute of Advanced Industrial Science and Technology (AIST) has found the natural compounds from Ashwagandha  have the potential to be an effective novel coronavirus preventive drug.

The researchers targeted the main SARS-CoV-2’s enzyme for splitting proteins, known as the main protease (Mpro), that plays a key role in mediating viral replication. This is an attractive drug target for this virus, and as humans don’t naturally have this enzyme, compounds that target Mpro are likely to have lowcyclodextrin.The findings offer some preventive and therapeutic value for the management of fatal COVID-19 pandemics.

Withanolides an active constituent in Ashwagandha can offer some preventive or even therapeutic value for the treatment and prevention of pandemic disease covid19.

The well-trusted reputation of Ashwagandha as an immunity enhancer forms a basis of the recent initiative of the Indian government in forming an Interdisciplinary Task Force to launch its clinical research studies related to  COVID-19 disease, the current research report  provides hints on its direct anti-viral activities against corona infection.

FROM AWARD-WINNING AUTHOR DR GOVIND SHUKLA, NUTRITION EXPERT

GOVIND SHUKLA

mail lactonovaresearch44@gmail.com |whatsup 8756536895

Govind Shukla, Specializes in Pharmacology, Toxicology, Nutraceuticals & Herbal Drugs has published More than 100 research papers in National & International Journals. He is also a reviewer of International Journal of Pharmacology & pharmacotherapeutics, Chief editor of IJPNR Journal & Freelance Medical Writer for Different publication Groups including Lambert Academic Publishing Saarbrucken, Germany.